Revenue: As of FY2025 Q2, the actual value is USD 621.86 M, beating the estimate of USD 611.71 M.EPS: As of FY2025 Q2, the actual value is USD 0.84, missing the estimate of USD 1.29.EBIT: As of FY2025 Q2, the actual value is USD 48.33 M.<h3>Home Health Segment</h3><ul><li>Net Service Revenue: $396.2 million for Q2 2025, compared to $377.4 million for Q2 2024.</li><li>Operating Income: $67.3 million for Q2 2025, compared to $67.1 million for Q2 2024.</li><li>Cost of Service: $232.0 million for Q2 2025, compared to $216.0 million for Q2 2024.</li><li>General and Administrative Expenses: $94.9 million for Q2 2025, compared to $92.4 million for Q2 2024.</li></ul><h3>Hospice Segment</h3><ul><li>Net Service Revenue: $215.0 million for Q2 2025, compared to $204.0 million for Q2 2024.</li><li>Operating Income: $54.4 million for Q2 2025, compared to $49.9 million for Q2 2024.</li><li>Cost of Service: $109.1 million for Q2 2025, compared to $104.6 million for Q2 2024.</li><li>General and Administrative Expenses: $50.7 million for Q2 2025, compared to $48.7 million for Q2 2024.</li></ul><h3>High Acuity Care Segment</h3><ul><li>Net Service Revenue: $10.7 million for Q2 2025, compared to $9.8 million for Q2 2024.</li><li>Operating Loss: -$3.4 million for Q2 2025, compared to -$2.8 million for Q2 2024.</li><li>Cost of Service: $7.4 million for Q2 2025, compared to $6.4 million for Q2 2024.</li><li>General and Administrative Expenses: $5.9 million for Q2 2025, compared to $5.4 million for Q2 2024.</li></ul><h3>Cash Flow</h3><ul><li>Operating Cash Flow: $63.5 million for the six months ended June 30, 2025, compared to $45.7 million for the same period in 2024.</li><li>Free Cash Flow: Not explicitly stated, but cash used in investing activities was -$2.3 million for the six months ended June 30, 2025.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Proposed Merger: Amedisys is involved in a proposed merger with UnitedHealth Group, which is subject to various conditions including regulatory approvals and litigation outcomes.</li><li>CMS Payment Updates: CMS issued updates for hospice and home health payment rates, with expected impacts of a 2.4% increase for hospice and a 6.4% decrease for home health in 2026.</li></ul><h3>Unique Metrics</h3><ul><li>Medicare Revenue: Represents 68% of consolidated net service revenue for the three and six-month periods ended June 30, 2025.</li></ul><h3>Priority</h3><ul><li>Merger-Related Expenses: Significant merger-related expenses impacting financial results, totaling $26.3 million for Q2 2025.</li></ul>

Amedisys | 10-Q: FY2025 Q2 Revenue Beats Estimate at USD 621.86 M